A. Creatinine Phosphokinase (CPK) Elevation
- Myocardial Infarction (Increased MB Fraction)
- Cardiac troponin appears more sensitive indicator for cardiac damage than CPK
- Myocardial Cell Death due to procedures (PCI)
- Rhabdomyolysis (Crush injury; severe dehydration with muscle breakdown)
- Muscular Dystrophy*
- Inflammatory Myostitis*: Dermatomyositis / Polymyositis
- Hoffman's Syndrome: myositis due to hypothyroidism
- Muscle Trauma, Intramuscular Injection
- Brain Infarction (stroke), Seizure, Neuroleptic Malignant Syndrome: BB fraction of CK
- CK is produced by some Prostatic and Bronchogenic CAs
- *Note that regenerating skeletal muscle often expresses the MB isozyme of CK
B. Cardiac Troponin Elevation [1]
- Myocardial infarction (MI) - best test for ruling out MI
- Nonthrombotic Myocardial Ischemia
- Coronary vasospasm
- Intracranial hemorrhage or stroke
- Sympathomimetic agent overdose
- Demand Ischemia
- Sepsis / SIRS
- Severe hypotension or hypovolemia
- Supraventricular tachyarrhythmias
- Left ventricular hypertrophy
- Direct Myocardial Damage
- Cardiac contusion
- Direct current cardioversion
- Chemotherapy
- Myocarditis / Pericarditis
- Cardiac infiltrative disorders (restrictive cardiomyopathies)
- Myocardial Strain
- Congestive heart failure (CHF) - elevated troponin I or T associated with 2.6X mortality risk in acute cecompensated CHF [7]
- Pulmonary embolism
- Pulmonary hypertension or emphysema
- Strenuous exercise
- Chronic renal insufficiency - unknown cause
- Increases in troponins associated with overall increased risk of any cardiovascular mortality [8]
A. AST (SGOT) and/or ALT (SGPT) Elevations - Over 30% of adults with initially elevated AST, ALT or bilirubin levels will be reclassified as normal on retesting [6]
- Alcoholic Liver Disease (AST usually <4 fold elevated ; AST/ALT ratio >2)
- Drug Related Hepatitis (partial list)
- Acetaminophen (Tylenol®, Paracetamol® and others) - even at recommended doses [4]
- Anti-Mycobacterial Agents: isoniazid, rifampin, rifampicin, rifamycin
- Tetracyclines
- Antifungal agents: griseofulvin, ketoconazole, fluconazole, itraconazole
- Trimethoprim-Sulfamethoxazole (TMP/SMX)
- Niacin
- HMG-CoA reductase inhibitors (statins)
- Nonsteroidal anti-inflammatory drugs (NSAIDS) - usually high dose
- Methotrexate (Rheumatrex® and others)
- Alpha-methyldopa
- Vitamin A
- Propylthiouracil (PTU)
- Halothane
- Various chemotherapy
- Herbal agents: Echinacea [5]
- Acute Hepatitis 'Viral Hepatitis"
- Viral (Hepatitis A, B, C, E)
- Other Viruses (acute and chronic): EBV, CMV, adenovirus, HSV, Yellow Fever, VZV
- Drug Related
- Chronic Hepatitis
- Chronic active viral hepatitis
- Chronic Autoimmune hepatitis
- Metobolic: Hemochromatosis, Wilson's Disease, alpha1-antitrypsin deficiency
- Toxins: carbon tetrachloride, benzenes
- Other infectious processes
- Focal Infections: Tuberculosis, MAI, Amoebiasis, Abscess (bacterial, fungal)
- Pneumonia (especially pneumococcal, legionella)
- Ascending Cholangitis
- Vascular Disease
- Anoxia (hypotension) - Shock Liver (extremely high and rapid increase in LFTs)
- Budd-Chiari Syndrome
- Severe Right Sided Congestive Heart Failure
- Hepatic Venoocclusive Disease
- Surgical / post-surgical (fibrotic) obstruction of biliary ducts
- HELLP Syndrome (Pregnancy)
- Hemorrhage
- Elevated liver enzymes
- Low platelets
- Total Parenteral Nutrition (TPN)
- ALT is more specific for liver than AST
- AST elevated in erythrocyte hemolysis/destruction
- AST elevated in myocardial ischemia and infarction
- AST generally > ALT in alcoholic hepatitis
B. Alkaline Phosphatase Elevations
- Differential below with little or no AST, ALT elevations
- Liver (heat stable) and bone (heat labile) produce most of body's Alkaline Phosphate
- Gallstone Related
- Cholelithiasis usually with jaundice
- Acute cholecystitis
- Sclerosing cholangitis - predmoninantly male, many have Inflammatory Bowel Disease
- Primary biliary cirrhosis - Majority of cases in middle aged (20-45) females
- Steatosis: fatty liver (alcoholic, tetracyclines, pregnancy)
- Cholangiocarcinoma
- Infection or Tumor Infiltration in Bone or Liver
- Granulomatous Disease
- Sarcoid
- Tuberculosis
- Fungal Infection
- Various hepatic granulomatous diseases
- Histiocytosis
- 5'-nucleotidase (5'NT) is highly specific for liver cholestasis (obstruction)
- Gamma-glutamyl transferase (GGT) is less specific and is inducible with drugs
A. Low TSH, Raised Free T3 or Free T4 - Graves' Disesae
- Multinodular goiter
- Toxic nodule
- Transient Thyroiditis
- Postpartum
- Silent (lymphocytic)
- Post-viral (granulomatous, subacute, DeQuervain's)
- Thyroxine ingestion (rare)
- Amiodarone therapy (rare)
- Pregnancy Related: Gestational thyrotoxicosis, molar pregnancy
B. Low TSH, Normal Free T3/T4
- Subclinical Hyperthryoidism
- Thyroxine Ingestion
- Rare
- Glucocorticoid Therapy
- Dopamine Infusion
- Dobutamine Infusion
- Non-thyroidal illness
C. Low or Normal TSH, Low Free T3/T4
- Non-thyroidal illness
- Recent treatment for hyperthyroidism
- Rare
- Pituitary Disease (secondary hypothyroidism)
- Congenital TSH or TRH deficiency
D. Raised TSH, Low Free T3/T4
- Primary Hypothyroidism
- Common
- Chronic autoimmune thyroiditis
- Post-radioiodine
- Post-thyroidectomy
- Hypothyroid phase of transient thyroiditis
- If rapidly enlarging goiter, consider thyroid lymphoma
- Rare
- Anti-thyroid peroxidase antibody negative; no radiation or surgery
- Drugs: amiodarone, lithium, interferons, interleukin-2, anti-CD52 (Campath)
- Idoine deficiency
- Amyloid goiter
- Reidel's thyroiditis
- Congenital
- Thyroid tissue absent syndromes
- Thyroid tissue present - iodine transport or organification defects
- Thyroglobulin synthetic defect
- TSH-receptor defects
E. Raised TSH, Normal Free T3/T4
- Subclinical autoimmune hypothyroidism (common)
- Rare
- Interfering heterophile antibody
- Intermittent T4 therapy for hypothyroidism
- Drugs: amiodarone, sertraline, cholestyramine
- Recovery phase after non-thyroidal illness
- Congenital
- TSH-receptor defects
- Resistance to TSH associated with other defects
- Pendred's Syndrome
References
- Jeremias A and Gibson CM. 2005. Ann Intern Med. 142(9):767
- Pratt DS and Kaplan MM. 2000. NEJM. 342(17):1266

- Dayan CM. 2001. Lancet. 357(9256):619

- Watkins PB, Kaplowitz N, Shattery JT, et al. 2006. JAMA. 296(1):87

- Echinacea. 2002. Med Let. 44(1127):29

- Lazo M, Selvin E, Clark JM. 2008. Ann Intern Med. 148(5):348

- Peacock WF IV, De Marco T, Fonarow GC, et al. 2008. NEJM. 358(20):2117

- Zethelius B, Berglund L, Sundstrom J, et al. 2008. NEJM. 358(20):2107
